News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cannabis Science Inc. Initiates Preclinical Investigation of CS-TATI-1 for European Studies for Squamous/Basal Cell Carcinomas and Kaposi's Sarcoma


9/24/2012 9:42:11 AM

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science (NASD OTC: CBIS), a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges, is pleased to announce preclinical investigations being initiated in Europe for Squamous/Basal Cell carcinomas and Kaposi’s sarcoma based on inhibition of carcinogenicity utilizing cannabinoids that have been demonstrated in recent studies to significantly affect tumor necrosis.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES